Pfizer Inc (NYSE:PFE)

54.00
Delayed Data
As of May 26
 +0.29 / +0.54%
Today’s Change
38.48
Today|||52-Week Range
61.71
-8.55%
Year-to-Date
Why Novavax Was Tumbling by 12% This Week
May 26 / MotleyFool.com - Paid Partner Content
Top 5 1st Quarter Trades of Sanders Capital, LLC
May 25 / GuruFocus News - Paid Partner Content
Better Dividend Stock: Pfizer or Merck?
May 26 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Reports More Positive Data From Etrasimod Study
May 25 / Zacks.com - Paid Partner Content
Top 5 1st Quarter Trades of Sanders Capital, LLC
May 25 / GuruFocus News - Paid Partner Content
Better Buy Ahead of FDA Meetings: Moderna vs. Novavax
May 25 / MotleyFool.com - Paid Partner Content
Analysts Tab Veeva Systems as a Top Value Pick
May 25 / GuruFocus News - Paid Partner Content
Sanders Capital, LLC Buys 2, Sells 3 in 1st Quarter
May 24 / GuruFocus News - Paid Partner Content
How Vaccine Cash Could Fuel Pfizer's Future Growth
May 25 / MotleyFool.com - Paid Partner Content
Top 5 1st Quarter Trades of CHELSEA COUNSEL CO
May 24 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close53.71
Today’s open53.99
Day’s range53.89 - 54.91
Volume23,516,309
Average volume (3 months)29,863,010
Market cap$294.4B
Data as of 4:00pm ET, 05/26/2022

Growth & Valuation

Earnings growth (last year)+128.42%
Earnings growth (this year)+52.42%
Earnings growth (next 5 years)-2.70%
Revenue growth (last year)+93.97%
P/E ratio12.2
Price/Sales4.15
Price/Book3.82

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+6.46+2.10%
ABBVAbbVie-1.37-0.90%
MRKMerck-1.43-1.53%
AZNAstraZeneca-0.13-0.19%
Data as of 4:01pm ET, 05/26/2022

Financials

Next reporting dateAugust 2, 2022
EPS forecast (this quarter)$1.81
Annual revenue (last year)$81.3B
Annual profit (last year)$22.1B
Net profit margin27.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts